The Prevalence of Endoscopic and Histologic Features in Patients With Bile Gastropathy, Non-bile Gastropathy and No Gastropathy Cohorts
| Endoscopy features | Bile gastropathy (n = 90) |
Non-bile gastropathy (n = 121) |
No gastropathy (n = 51) |
|
|---|---|---|---|---|
| Erythema | 88.9% | 63.6% | 0.0% | < 0.001 |
| Erosions | 8.9% | 22.3% | 0.0% | 0.016 |
| Ulcers | 1.1% | 6.6% | 0.0% | 0.107 |
| Polyps | 0.0% | 8.3% | 0.0% | 0.046 |
| Atrophy | 1.1% | 1.7% | 0.0% | 0.796 |
| Gastropathy involvement | 0.148 | |||
| Antrum | 66.3% | 65.0% | 0.0% | |
| Body | 32.6% | 28.2% | 0.0% | |
| Fundus | 1.2% | 6.8% | 0.0% | |
| Pathology description | Bile gastropathy (n = 90) |
Non-bile gastropathy (n = 121) |
No gastropathy (n = 51) |
|
| Normal mucosa | 0.0% | 0.0% | 95.0% | |
| Foveolar hyperplasia | 82.2% | 83.5% | 0.0% | |
| Reactive glandular changes | 84.4% | 82.6% | 0.0% | |
| Gastritis (any) | 37.8% | 7.4% | 0.0% | |
| Minimal gastritis | 35.6% | 3.3% | 0.0% | |
| Mild gastritis | 2.2% | 3.3% | 0.0% | |
| Moderate gastritis | 0.0% | 0.8% | 0.0% | |
| Edema | 30.0% | 0.8% | 5.0% | |
| Chronic inactive inflammation | 5.6% | 6.6% | 0.0% | |
| Chronic active inflammation | 7.8% | 1.7% | 0.0% | |
| Intestinal metaplasia | 2.2% | 1.7% | 0.0% |